Clinical Trials Logo

IgA Patients clinical trials

View clinical trials related to IgA Patients.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02942381 Completed - Hydroxychloroquine Clinical Trials

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Start date: September 13, 2016
Phase: Phase 2
Study type: Interventional

The investigators study will recruit IgA nephropathy patients with proteinuria range from 0.75 to 3.5g/d even after three-month treatment by sufficient ACEi/ARB. The patients were treated with Hydroxychloroquine 200-400mg/d according to eGFR. The proteinuria will recorded every two months and total four months. Then, the drug will be stopped for two months for observation of change of proteinuria.